C. trachomatis Antibody (130): sc-57668

C. trachomatis Antibody (130) is a mouse monoclonal IgG2a antibody that detects C. trachomatis protein by enzyme-linked immunosorbent assay (ELISA). Anti-C. trachomatis antibody (130) is available as a non-conjugated isotype antibody. Chlamydia trachomatis is a significant human pathogen responsible for various diseases, including sexually transmitted infections and trachoma, which can lead to blindness. C. trachomatis protein plays a crucial role in the bacterium′s ability to invade host cells and evade the immune response, making C. trachomatis protein a key target for diagnostic and therapeutic strategies. C. trachomatis has a unique biphasic developmental cycle, transitioning between the infectious elementary body and the replicative reticulate body, which is essential for survival and propagation within the host. Understanding the dynamics of this cycle and the role of specific proteins in mediating these processes is vital for developing effective interventions against Chlamydia infections. Anti-C. trachomatis antibody (130) specifically recognizes epitopes in the variable region of the major outer membrane protein (MOMP), which is critical for the bacterium′s adherence to host cells and is a major target for immune recognition. With the ability to detect C. trachomatis in various samples, C. trachomatis monoclonal antibody (130) serves as an invaluable tool for researchers and clinicians working to combat the impact of this pathogen on public health.